Found 367 results for healthcare-and-pharmaceutical

Pill bottle deal tombstone marking the divestment by Stockholm, Sweden-based Medivir of the pharmaceutical firm Biophausia.

Pill-shaped crystal tombstone marking the issue of bonds by Israeli drugmaker Teva Pharmaceutical.

Custom tombstone recognizing legal advisory work in two transactions involving pharmaceutical company Shionogi: an acquisition and a licensing agreement.

Density bottle-themed Lucite tombstone commemorating a Swiss Franc-denominated bond issue. Credit Suisse and Deutsche Bank served as joint active book runners for this debt issue by Swiss pharmaceutical firm Vifor Pharma.

Custom crystal commemorating a research collaboration involving Neurocrine Biosciences and Jnana Therapeutics. The research centers on finding new small-molecule therapeutics targeting central nervous system disorders.

Pyramid-shaped deal toy commemorating convertible notes issued by Ligand Pharmaceuticals, based in San Diego. Goldman Sachs and Barclays acted as Joint Book-Running Managers for the issue.

Custom crystal tombstone marking a private placement by Swiss biopharmaceutical company Auris Medical. Ladenburg Thalmann acted as exclusive placement agent.

Custom Lucite deal toy commemorating the acquisition of San Diego-based Ultimate Labs, a testing laboratory for the pharmaceutical, biotechnology, medical device, and food industries.

Custom Lucite, with an embedded champagne cork, celebrating the approval by the Food and Drug Administration (FDA) of the obesity treatment Plenity. Plenity was developed by Boston-based biotech firm Gelesis.